| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Clayton Trier last filed a Form 4 in May 2025, as Director at USPH. From March 2015 to May 2025, the filings on record show 0 open-market purchases and 12 sales. Clayton Trier's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Clayton Trier's trades have earned a middling insider score of 66/100 across 9 rated trades. Over a 12-month horizon, 77.8% of those trades were profitable, with an average 12-month return of +7.8%.
At the last filing, the largest reported position was 8,306 shares of USPH. The USPH filings lean toward selling, a net 26,380 shares.
Shares as reported in the last Form 4 for each company; the most recent is from May 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2015 | USPH U S Physical Therapy Inc /nv | Director | Sell | 4,500 | $55.23 | $248,535.00 | -28.6% | |
| Mar 9, 2015 | USPH U S Physical Therapy Inc /nv | Director | Sell | 3,250 | $45.05 | $146,412.50 | -20.0% |